Section Arrow
Quote
BMRA.NASDAQ
- Biomerica
(Financial Status)
Quotes are at least 15-min delayed:2025/04/30 00:08 EDT
Last
 3.61
-0.23 (-5.99%)
Day High 
3.96 
Prev. Close
3.84 
1-M High
4.88 
Volume 
33.37K 
Bid
3.57
Ask
3.9
Day Low
3.61 
Open
3.82 
1-M Low
3.1754 
Market Cap 
9.78M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.84 
20-SMA 4.04 
50-SMA 5.01 
52-W High 10.16 
52-W Low 1.932 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.16/--
Enterprise Value
10.23M
Balance Sheet
Book Value Per Share
2.17
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
5.75M
Operating Revenue Per Share
2.13
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed：2025/04/30 00:08 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia,and also has its presence in Europe, North America, Middle East and South America.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.